Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase 1b Study of HSP90 Inhibitor, AT13387 (onalespib) in Combination with Paclitaxel in Patients with Advanced, Triple Negative Breast Cancer.CIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: ActiveReview Status: Available to Open
